Skip to main content

Psoriasis

  • Chapter
  • First Online:
Stress and Skin Disorders

Abstract

Psoriasis is a chronic inflammatory multi organ disease that affects 1–3 % of the general population. The etiology of psoriasis is not fully understood. It is considered a multifactorial disease that involves both genetic environmental influences. Among these factors, stress has been considered as an important role in the onset and exacerbation of psoriasis Heller (Skin Therapy Lett 16(5):1–4, 2011). Psychological stress may be also a consequence of psoriasis. Social stigmatization, rejection by the family and friends with consequent profound effect on self-confidence, self-image and sense of well being are most commonly seen in psoriasis patient. Psychiatric comorbidity in psoriasis patients is well documented in the literature. It is highly recommended that every patient of psoriasis should be thoroughly evaluated for the psychosocial percussions of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Weger W. Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents. Br J Pharmacol. 2010;160(4):810–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Rahman M, Alam K, Ahmad MZ, Gupta G, Afzal M, Akhter S, Kazmi I, Jyoti, Ahmad FJ, Anwar F. Classical to current approach for treatment of psoriasis: a review. Endocr Metab Immune Disord Drug Targets. 2012;12(3):287–302.

    Google Scholar 

  3. Ritchlin CT, Krueger JG. New therapies for psoriasis and psoriatic arthritis. Curr Opin Rheumatol. 2016;28(3):204–10.

    Article  CAS  PubMed  Google Scholar 

  4. Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4–5):490–5. doi:10.1016/j.autrev.2014.01.008. Epub 2014 Jan 13.

    Article  PubMed  Google Scholar 

  5. Alexis AF, Blackcloud P. Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances. Desai SR, Alexis A, eds. J Clin Aesthet Dermatol. 2014;7(11):16–24.

    Google Scholar 

  6. Sampogna F, Gisondi P, Melchi CF, Amerio P, Girolomoni G, Abeni D. Prevalence of symptoms experienced by patients with different clinical types of psoriasis. Br J Dermatol. 2004;151(3):594–9.

    Article  CAS  PubMed  Google Scholar 

  7. Heller MM, Lee ES, Koo JY. Stress as an influencing factor in psoriasis. Skin Therapy Lett. 2011;16(5):1–4.

    CAS  PubMed  Google Scholar 

  8. Sathyanarayana Rao TS, Basavaraj KH, Das K. Psychosomatic paradigms in psoriasis: psoriasis, stress and mental health. Indian J Psychiatry. 2013;55(4):313–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Gupta MA, Gupta AK, Ellis CN, Voorhees JJ. Some psychosomatic aspects of psoriasis. Adv Dermatol. 1990;5:21–30.

    CAS  PubMed  Google Scholar 

  10. Yosipovitch G, Tang M, Dawn AG, Chen M, Goh CL, Huak Y, Seng LF. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol. 2007;87(2):135–9.

    Article  PubMed  Google Scholar 

  11. Arndt J, Smith N, Tausk F. Stress and atopic dermatitis. Curr Allergy Asthma Rep. 2008;8(4):312–7.

    Article  CAS  PubMed  Google Scholar 

  12. Chung MC, Symons C, Gilliam J, Kaminski ER. Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria. Psychol Health. 2010;25(4):477–90.

    Article  PubMed  Google Scholar 

  13. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mørk C, Sigurgeirsson B. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol. 2004;18(1):27–36.

    Article  CAS  PubMed  Google Scholar 

  14. Verhoeven EW, Kraaimaat FW, Jong EM, Schalkwijk J, van de Kerkhof PC, Evers AW. Effect of daily stressors on psoriasis: a prospective study. J Invest Dermatol. 2009;129:2075–7.

    Article  CAS  PubMed  Google Scholar 

  15. Evers AW, Verhoeven EW, Kraaimaat FW, de Jong EM, de Brouwer SJ, Schalkwijk J, et al. How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol. 2010;163(5):986–91.

    Article  CAS  PubMed  Google Scholar 

  16. Malhotra SK, Mehta V. Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria. Indian J Dermatol Venereol Leprol. 2008;74:594–9.

    Article  CAS  PubMed  Google Scholar 

  17. Moynihan J, Rieder E, Tausk F. Psychoneuroimmunology: the example of psoriasis. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2010;145(2):221–8.

    CAS  Google Scholar 

  18. Elloso MM, Gomez-Angelats M, Fourie AM. Targeting the Th17 pathway in psoriasis. J Leukoc Biol. 2012;92(6):1187–97. doi:10.1189/jlb.0212101. Epub 2012 Sep 7.

    Article  CAS  PubMed  Google Scholar 

  19. Mease PJ. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis. Curr Opin Rheumatol. 2015;27(2):127–33.

    Article  CAS  PubMed  Google Scholar 

  20. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445(7128):648–51.

    Article  CAS  PubMed  Google Scholar 

  21. Brunoni AR, Santos IS, Sabbag C, Lotufo PA, Benseñor IM. Psoriasis severity and hypothalamic-pituitary-adrenal axis function: results from the CALIPSO study. Braz J Med Biol Res. 2014;47(12):1102–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Loite U, Kingo K, Reimann E, Reemann P, Vasar E, Silm H, Kõks S. Gene expression analysis of the corticotrophin-releasing hormone-proopiomelanocortin system in psoriasis skin biopsies. Acta Derm Venereol. 2013;93(4):400–5.

    Article  PubMed  Google Scholar 

  23. Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE. Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol. 2005;153(6):1114–20.

    Article  CAS  PubMed  Google Scholar 

  24. Karanikas E, Harsoulis F, Giouzepas I, Griveas I. Stimulation of the hypothalamic-pituitary-adrenal axis with corticotropin releasing hormone in patients with psoriasis. Hormones (Athens). 2007;6(4):314–20.

    Article  Google Scholar 

  25. Kadam DP, Suryakar AN, Ankush RD, Kadam CY, Deshpande KH. Role of oxidative stress in various stages of psoriasis. Indian J Clin Biochem. 2010;25(4):388–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Attwa E, Swelam E. Relationship between smoking-induced oxidative stress and the clinical severity of psoriasis. J Eur Acad Dermatol Venereol. 2011;25(7):782–7.

    Article  CAS  PubMed  Google Scholar 

  27. Bakry OA, El Hefnawy S, Mariee AH, El Gendy Y. Urinary biopyrrins: a new marker of oxidative stress in psoriasis. Indian J Dermatol. 2016;61(2):169–73.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Sampogna F, Tabolli S, Abeni D. Living with psoriasis prevalence of shame, anger, worry and problems in daily activities and social life. Acta Derm Venereol. 2012;92:299–303.

    Article  PubMed  Google Scholar 

  29. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effects of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512–8.

    Article  PubMed  Google Scholar 

  30. Kurd SK, Troxel AB, Critis-Christoph P, et al. The risk of depression, anxiety and suicidality in patients with psoriasis: a population based cohort study. Arch Dermatol. 2010;146:891–5.

    PubMed  PubMed Central  Google Scholar 

  31. Egeberg A, Hansen PR, Gislason GH, et al. Risk of self-harm and non-fatal suicide attempts, and completed suicide in patients with psoriasis – a population-based cohort study. Br J Dermatol. 2016. doi: 10.1111/bjd.14633 [Epub ahead of Print].

  32. Kimball AB, Gieler U, Linder D, et al. Psoriasis: Is the impairment to a patient’s life cumulative? J Eur Acad Dermatol Venereol. 2010;24:989–1004.

    CAS  PubMed  Google Scholar 

  33. Mizara A, Papadoupolos I, McBride SR. Core beliefs and psychological distress in patients with psoriasis and atopic eczema attending secondary care: the role of schemas in chronic skin disease. Br J Dermatol. 2012;166:986–93.

    Article  CAS  PubMed  Google Scholar 

  34. Devrimici-Ozguven H, Kundakci TN, Kumbasar H, et al. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14:267–71.

    Article  Google Scholar 

  35. Kleyn CE, McKie S, Ross R, et al. Diminished neural and cognitive responses to facial expressions of disgust in patients with psoriasis: a functional magnetic resonance imaging study. J Invest Dermatol. 2009;129:2613–9.

    Article  CAS  PubMed  Google Scholar 

  36. Tee SI, Lim ZV, Theng CT, et al. A prospective cross sectional study of anxiety and depression in patients with psoriasis in Singapore. J Eur Acad Dermatol Venereol. 2016;30(7):1159–64. doi:10.1111/jdv13615.

    Article  CAS  PubMed  Google Scholar 

  37. Eghlileb AM, Davies EEG, Finlay AY. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol. 2007;156:1245–50.

    Article  CAS  PubMed  Google Scholar 

  38. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severly affected patients. Int J Dermatol. 1997;36:259–62.

    Article  CAS  PubMed  Google Scholar 

  39. Sampogna F, Gisondi P, Tabolli S, et al. Impairment of sexual life in patients with psoriasis. Dermatology. 2007;214:144–50.

    Article  PubMed  Google Scholar 

  40. Goulding JM, Price CL, Defty CL, et al. Erectyl dysfunction in patients with psoriasis: increased prevalence, an unmet need, and a chance to intervene. Br J Dermatol. 2011;164:103–9.

    Article  CAS  PubMed  Google Scholar 

  41. Mills CM, Srivastava ED, Harvey IM. Smoking habits in psoriasis: a case controlled study. Br J Dermatol. 1992;127:18–21.

    Article  CAS  PubMed  Google Scholar 

  42. Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol. 1993;28:730–2.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katlein França MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

França, K., Jafferany, M. (2017). Psoriasis. In: França, K., Jafferany, M. (eds) Stress and Skin Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-46352-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-46352-0_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-46351-3

  • Online ISBN: 978-3-319-46352-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics